Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
D P Tashkin
Dr D P Tashkin, University of California, Los Angeles, Los Angeles, CA, USA; firstname.lastname@example.org
randomised placebo-controlled trial (Understanding Potential Long-Term Impacts on Function with Tiotropium [UPLIFT]). ClinicalTrials.gov NCT00144339.
blinded (clinicians, patients, data collectors, and outcome adjudication committee).*
490 centres in 37 countries worldwide.
5993 patients ⩾40 years of age (mean age 65 y, 75% men) who had COPD, a history of ⩾10 pack-years of smoking, and postbronchodilation FEV1 ⩽70% of predicted and ⩽70% of FVC. Exclusion criteria included a history of asthma …
Source of funding: Boehringer Ingelheim and Pfizer.